• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MAVS在卵巢癌中的预后意义及其潜在生物学机制分析

An Analysis Regarding the Prognostic Significance of MAVS and Its Underlying Biological Mechanism in Ovarian Cancer.

作者信息

Chen Lifeng, Hou Jing, You Bingbing, Song Feifei, Tu Xinyi, Cheng Xiaodong

机构信息

Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Department of Gynecology, Zhejiang Provincial People's Hospital, Hangzhou, China.

出版信息

Front Cell Dev Biol. 2021 Oct 14;9:728061. doi: 10.3389/fcell.2021.728061. eCollection 2021.

DOI:10.3389/fcell.2021.728061
PMID:34722508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8551630/
Abstract

The present study evaluates the value of mitochondrial antiviral signaling (MAVS) expression as a potential diagnostic biomarker and therapeutic target for ovarian cancer (OC) and analyses the underlying biological mechanism in this pathology. First, the association between MAVS expression determined by immunohistochemical (IHC) and clinical characteristics was systematically investigated. Overexpression of MAVS was associated with advanced clinical factors and poor survival of OC patients. Second, bioinformatics analyses, namely, gene expression, mutation analysis, gene set variation analysis (GSVA), gene set enrichment analysis (GSEA), and weighted gene co-expression network analysis (WGCNA), were performed to evaluate the potential biological functions of MAVS in OC. The results showed that MAVS may play a critical role in immune cell infiltration. CIBERSORT was applied to assess the infiltration of immune cells in OC. CD8+ T cells, γδT cells, and eosinophils had significantly negative correlations with MAVS expression. Finally, sensitivity analysis found that patients with high MAVS expression were predicted to be significantly less responsive to cisplatin and paclitaxel. In conclusion, these findings suggested that MAVS influences biological behavior by regulating the immune response and that it can be used as a predictive marker for poor prognosis in OC.

摘要

本研究评估线粒体抗病毒信号(MAVS)表达作为卵巢癌(OC)潜在诊断生物标志物和治疗靶点的价值,并分析该病理过程中的潜在生物学机制。首先,系统研究了免疫组织化学(IHC)测定的MAVS表达与临床特征之间的关联。MAVS过表达与OC患者的晚期临床因素和不良生存相关。其次,进行了生物信息学分析,即基因表达、突变分析、基因集变异分析(GSVA)、基因集富集分析(GSEA)和加权基因共表达网络分析(WGCNA),以评估MAVS在OC中的潜在生物学功能。结果表明,MAVS可能在免疫细胞浸润中起关键作用。应用CIBERSORT评估OC中免疫细胞的浸润情况。CD8 + T细胞、γδT细胞和嗜酸性粒细胞与MAVS表达呈显著负相关。最后,敏感性分析发现,MAVS高表达的患者预计对顺铂和紫杉醇的反应显著较低。总之,这些发现表明MAVS通过调节免疫反应影响生物学行为,并且它可以用作OC预后不良的预测标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/3fbeb4210aa8/fcell-09-728061-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/781e5b216d0d/fcell-09-728061-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/9bd734ae54f5/fcell-09-728061-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/3a8f93005477/fcell-09-728061-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/22eaf881f4dc/fcell-09-728061-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/e36124ec996f/fcell-09-728061-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/595192efed0a/fcell-09-728061-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/3fbeb4210aa8/fcell-09-728061-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/781e5b216d0d/fcell-09-728061-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/9bd734ae54f5/fcell-09-728061-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/3a8f93005477/fcell-09-728061-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/22eaf881f4dc/fcell-09-728061-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/e36124ec996f/fcell-09-728061-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/595192efed0a/fcell-09-728061-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf6/8551630/3fbeb4210aa8/fcell-09-728061-g007.jpg

相似文献

1
An Analysis Regarding the Prognostic Significance of MAVS and Its Underlying Biological Mechanism in Ovarian Cancer.MAVS在卵巢癌中的预后意义及其潜在生物学机制分析
Front Cell Dev Biol. 2021 Oct 14;9:728061. doi: 10.3389/fcell.2021.728061. eCollection 2021.
2
PDP1 Promotes Cell Malignant Behavior and Is Associated with Worse Clinical Features in Ovarian Cancer Patients: Evidence from Bioinformatics and In Vitro Level.PDP1 促进卵巢癌细胞的恶性行为,并与卵巢癌患者的临床特征恶化相关:来自生物信息学和体外水平的证据。
Comput Math Methods Med. 2022 Oct 14;2022:7397250. doi: 10.1155/2022/7397250. eCollection 2022.
3
A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.一种基于共表达网络分析和五种长链非编码RNA表达水平的新型卵巢癌风险评分系统。
BMC Med Genet. 2019 Jun 10;20(1):103. doi: 10.1186/s12881-019-0832-9.
4
Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.通过综合生物信息学分析鉴定 MEG8/miR-378d/SOBP 轴作为一个新的调控网络,并与卵巢癌中的免疫浸润相关。
Cancer Med. 2021 Apr;10(8):2924-2939. doi: 10.1002/cam4.3854. Epub 2021 Mar 19.
5
Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.鉴定与卵巢癌病理分级和预后相关的长链非编码 RNA。
J Cell Biochem. 2019 Sep;120(9):14444-14454. doi: 10.1002/jcb.28704. Epub 2019 Apr 29.
6
Increased Expression of Predicting Poor Survival of Epithelial Ovarian Cancer: Based on Comprehensive Analysis of , Clinical Samples, and the GEO Database.基于临床样本和 GEO 数据库的综合分析,上调的 预测上皮性卵巢癌不良预后:
DNA Cell Biol. 2021 Jan;40(1):36-60. doi: 10.1089/dna.2020.5823. Epub 2020 Nov 11.
7
The Immune-Related Gene ELF3 is a Novel Biomarker for the Prognosis of Ovarian Cancer.免疫相关基因ELF3是卵巢癌预后的新型生物标志物。
Int J Gen Med. 2021 Sep 10;14:5537-5548. doi: 10.2147/IJGM.S332320. eCollection 2021.
8
Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.基于基因表达综合数据库(GEO)的卵巢癌中 MicroRNA-9 的前瞻性通路信号和预后价值:一项生物信息学分析。
J Ovarian Res. 2021 Feb 9;14(1):29. doi: 10.1186/s13048-021-00779-z.
9
Association between tumor mutation burden and immune infiltration in ovarian cancer.卵巢癌中肿瘤突变负担与免疫浸润的相关性。
Int Immunopharmacol. 2020 Dec;89(Pt A):107126. doi: 10.1016/j.intimp.2020.107126. Epub 2020 Nov 11.
10
Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.基因共表达网络分析鉴定出 TICRR 和 PPIF 的过表达与子宫内膜癌的不良预后相关。
Aging (Albany NY). 2021 Jan 20;13(3):4564-4589. doi: 10.18632/aging.202417.

引用本文的文献

1
Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease.线粒体抗病毒信号蛋白:肾脏病治疗的潜在靶点。
Front Immunol. 2023 Oct 12;14:1266461. doi: 10.3389/fimmu.2023.1266461. eCollection 2023.
2
miR‑4732‑5p promotes ovarian cancer mobility by targeting MCUR1.微小RNA-4732-5p通过靶向线粒体钙单向转运体调节蛋白1促进卵巢癌转移。
Oncol Lett. 2023 Apr 20;25(6):245. doi: 10.3892/ol.2023.13831. eCollection 2023 Jun.
3
Identification of NAD Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy.

本文引用的文献

1
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.肿瘤微环境中与免疫抵抗和耐药性相关的方面。
Front Immunol. 2021 May 27;12:656364. doi: 10.3389/fimmu.2021.656364. eCollection 2021.
2
LRRK2 inhibition potentiates PARP inhibitor cytotoxicity through inhibiting homologous recombination-mediated DNA double strand break repair.LRRK2抑制通过抑制同源重组介导的DNA双链断裂修复增强PARP抑制剂的细胞毒性。
Clin Transl Med. 2021 Mar;11(3):e341. doi: 10.1002/ctm2.341.
3
Cancer Statistics, 2021.癌症统计数据,2021.
卵巢癌预后和免疫治疗中NAD代谢衍生基因特征的鉴定
Front Genet. 2022 Jun 16;13:905238. doi: 10.3389/fgene.2022.905238. eCollection 2022.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
4
Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy.靶向氧化磷酸化以提高放疗与免疫联合治疗的疗效
Clin Cancer Res. 2021 Jun 1;27(11):2970-2978. doi: 10.1158/1078-0432.CCR-20-3913. Epub 2021 Jan 8.
5
Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma.胸腺素 β10 通过 PI3K/Akt 通路促进肺腺癌中肿瘤相关巨噬细胞 M2 转化和增殖。
Respir Res. 2020 Dec 22;21(1):328. doi: 10.1186/s12931-020-01587-7.
6
The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer.刺猬信号通路通过多药耐药蛋白 1 促进卵巢癌的化疗耐药性。
Oncol Rep. 2020 Dec;44(6):2610-2620. doi: 10.3892/or.2020.7798. Epub 2020 Oct 9.
7
STK35 Is Ubiquitinated by NEDD4L and Promotes Glycolysis and Inhibits Apoptosis Through Regulating the AKT Signaling Pathway, Influencing Chemoresistance of Colorectal Cancer.STK35 被 NEDD4L 泛素化,并通过调节 AKT 信号通路促进糖酵解、抑制细胞凋亡,影响结直肠癌的化疗耐药性。
Front Cell Dev Biol. 2020 Oct 8;8:582695. doi: 10.3389/fcell.2020.582695. eCollection 2020.
8
The Mitochondrial Protein MAVS Stabilizes p53 to Suppress Tumorigenesis.线粒体蛋白 MAVS 稳定 p53 以抑制肿瘤发生。
Cell Rep. 2020 Jan 21;30(3):725-738.e4. doi: 10.1016/j.celrep.2019.12.051.
9
Ribosome biogenesis restricts innate immune responses to virus infection and DNA.核糖体生物发生限制了先天免疫反应对病毒感染和 DNA 的反应。
Elife. 2019 Dec 16;8:e49551. doi: 10.7554/eLife.49551.
10
Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition.内皮细胞 CDS2 缺乏导致 VEGFA 介导的血管退化和肿瘤抑制。
Cell Res. 2019 Nov;29(11):895-910. doi: 10.1038/s41422-019-0229-5. Epub 2019 Sep 9.